The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses.
Teresa MarsdenNeil McCartanLouise BrownManuel RodriguezTom SyerGiorgio BrembillaMieke Van HemelrijckTon CoolenGerhardt AttardShonit PunwaniCaroline M MooreHashim U AhmedMark Embertonnull nullPublished in: PloS one (2022)
The consortium will develop, or adjust, risk models for PCa, and provide a platform for evaluating the role of novel diagnostics in the era of pre-biopsy MRI and targeted biopsy.